Vancouverman
New member
Not only does the protein HGF "exterminate" the Fibrosis in the lungs, and reduce Emphysema and restore the lung function, we already knew that, but now it does also reduce pulmonary hypertension... Last but not least it does also improve the Asthma so that the people dont have asthma attacks that badly. It all is now scientifically evident.
we neeeed to inhale HGF in a labratory setting.
Novel therapy for idiopathic pulmonary arterial hypertension: Can hepatocyte
growth factor be beneficial?
Ying-Hua Guo1, Long-Xiang Su1,2, Na Guo1, Chang-Ting Liu1
Nanlou Respiratory Disease Department, Chinese PLA General Hospital, Chinese PLA Postgraduate Medical School, Beijing 100853, China
Medical School, Nankai University, Tianjin 300071, China
J Geriatr Cardiol 2012; 9: 211−212. doi: 10.3724/SP.J.1263.2012.02131
citation:
3 HGF acts as a safe and effective factor for
pulmonary hypertension
HGF has less side effects. It does not cause edema like
VEGF. In addition, HGF specifically supports growth in
epithelial and endothelial cells, but not in myofibroblasts,
which may be required for antifibrotic tissue repair and endo-
thelium protection in IPAH. These beneficial effects of HGF
reverse the key pathogenetic cascades for the development
of IPAH. Recently, we have performed a animal study to
investigate whether expression of HGF through the trans-
plantation of genetically modified MSCs could offer thera-
peutic benefit. Compared with PAH and MSCs groups, hemo-
dynamic parameters, vascular smooth muscle cell proliferation,
extracellular matrix, and vascular density were significantly
improved in HGF group.
In summary, although the effectiveness and safety of
HGF for IPHA is preliminary, further evaluations in clinical
trials are needed. We believe HGF therapy sheds light on
the development of new therapeutic modalities aimed at
treating patients with IPAH.
...
end citation
we neeeed to inhale HGF in a labratory setting.
Novel therapy for idiopathic pulmonary arterial hypertension: Can hepatocyte
growth factor be beneficial?
Ying-Hua Guo1, Long-Xiang Su1,2, Na Guo1, Chang-Ting Liu1
Nanlou Respiratory Disease Department, Chinese PLA General Hospital, Chinese PLA Postgraduate Medical School, Beijing 100853, China
Medical School, Nankai University, Tianjin 300071, China
J Geriatr Cardiol 2012; 9: 211−212. doi: 10.3724/SP.J.1263.2012.02131
citation:
3 HGF acts as a safe and effective factor for
pulmonary hypertension
HGF has less side effects. It does not cause edema like
VEGF. In addition, HGF specifically supports growth in
epithelial and endothelial cells, but not in myofibroblasts,
which may be required for antifibrotic tissue repair and endo-
thelium protection in IPAH. These beneficial effects of HGF
reverse the key pathogenetic cascades for the development
of IPAH. Recently, we have performed a animal study to
investigate whether expression of HGF through the trans-
plantation of genetically modified MSCs could offer thera-
peutic benefit. Compared with PAH and MSCs groups, hemo-
dynamic parameters, vascular smooth muscle cell proliferation,
extracellular matrix, and vascular density were significantly
improved in HGF group.
In summary, although the effectiveness and safety of
HGF for IPHA is preliminary, further evaluations in clinical
trials are needed. We believe HGF therapy sheds light on
the development of new therapeutic modalities aimed at
treating patients with IPAH.
...
end citation